FIELD: veterinary medicine.
SUBSTANCE: invention refers to veterinary science, namely to a medicinal agent for normalizing metabolic processes in animals. Drug contains succinic acid, butafosfan and water, wherein components are taken in certain proportions. Additionally, the drug may contain 0.5 % novocaine.
EFFECT: use of the invention enables normalizing metabolic processes in animals, including those associated with liver function.
4 cl, 3 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
CONTENT FOR STIMULATING METABOLIC PROCESSES, IMMUNE SYSTEM, PREVENTION THE DISEASES AND DIARRHEA | 2014 |
|
RU2620554C2 |
AGENT FOR PREVENTION OF STRESS IN CHICKENS | 2015 |
|
RU2580761C1 |
IMMUNOMETABOLIC ANTHELMINTIC MEDICATION | 2009 |
|
RU2411944C1 |
METHOD FOR TREATMENT AND PREVENTION OF PARASITOSIS OF BIRDS WITH OPTIMIZATION OF THEIR METABOLISM AND NATURAL RESISTANCE | 2018 |
|
RU2694546C1 |
METHOD FOR CHRONIC STRONGYLOIDIASIS TREATMENT IN HORSES | 2007 |
|
RU2337671C1 |
COMPLEX ANTIBACTERIAL ANTIHELMINTHIC COMPOSITION FOR TREATMENT OF FARM ANIMALS AND BIRDS | 2017 |
|
RU2676326C1 |
METHOD FOR INCREASING EFFECTIVENESS OF VACCINATION OF BIRDS AGAINST INFLUENZA VIRUS | 2022 |
|
RU2805265C1 |
COMPOSITION FOR STIMULATION OF NONSPECIFIC RESISTANCE AND METABOLISM OF BROILER CHICKS | 2016 |
|
RU2621999C1 |
METHOD OF TREATING SALMONELLOSIS IN YOUNG CATTLE | 2022 |
|
RU2813776C1 |
HOMEOPATHIC MEDICINAL AGENT REGULATING METABOLIC PROCESSES IN ANIMALS | 2000 |
|
RU2164798C1 |
Authors
Dates
2019-09-26—Published
2019-01-18—Filed